Literature DB >> 7625790

Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography, a novel, noninvasive method for measuring responses to antifungal therapy.

T J Walsh1, K Garrett, E Feurerstein, M Girton, M Allende, J Bacher, A Francesconi, R Schaufele, P A Pizzo.   

Abstract

Pulmonary infiltrates in neutropenic hosts with invasive aspergillosis are due to vascular invasion and hemorrhagic infarction. In order to measure the effect of antifungal compounds on this organism-mediated tissue injury, we monitored the course of pulmonary infiltrates by serial ultrafast computerized tomography (UFCT) in persistently granulocytopenic rabbits with experimental invasive pulmonary aspergillosis. The course of pulmonary lesions measured by serial UFCT scans was compared with those measured by conventional chest radiography, histopathological resolution of lesions, and microbiological clearance of Aspergillus fumigatus. Treatment groups included either amphotericin B colloidal dispersion in dosages of 1, 5, and 10 mg/kg of body weight per day intravenously or conventional desoxycholate amphotericin B at 1 mg/kg/day intravenously. Therapeutic monitoring of pulmonary lesions by UFCT demonstrated a significant dose-response relationship. Lesions continued to progress in untreated controls, whereas lesions in treated rabbits initially increased and then decreased in response to antifungal therapy in a dosage-dependent manner (P < or = 0.05 to P < or = 0.005, depending upon the groups compared). This same trend of resolution of lesions in response to antifungal therapy was also demonstrated by postmortem examination and by microbiological clearance of the organism. These data indicated that amphotericin B colloidal dispersion at 5 and 10 mg/kg/day exerted a more rapid rate of clearance of lesions than conventional amphotericin B. UFCT was more sensitive than conventional chest radiography in detecting lesions due to invasive pulmonary aspergillosis (P < 0.05 to P < 0.005, depending upon the groups compared). These findings establish a correlation among UFCT-defined lesions, microbiological response, and resolution of pathologically defined lesions in experimental invasive pulmonary aspergillosis. Serial monitoring of UFCT-defined lesions of aspergillosis provides a novel system for determining the antifungal response of organism-mediated tissue injury.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7625790      PMCID: PMC162684          DOI: 10.1128/AAC.39.5.1065

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

Review 1.  Ultrafast cardiac CT scanning.

Authors:  J A Rumberger; M J Lipton
Journal:  Cardiol Clin       Date:  1989-08       Impact factor: 2.213

2.  Chronic silastic central venous catheterization for induction, maintenance and support of persistent granulocytopenia in rabbits.

Authors:  T J Walsh; J Bacher; P A Pizzo
Journal:  Lab Anim Sci       Date:  1988-08

3.  CT of invasive pulmonary aspergillosis.

Authors:  J E Kuhlman; E K Fishman; P A Burch; J E Karp; E A Zerhouni; S S Siegelman
Journal:  AJR Am J Roentgenol       Date:  1988-05       Impact factor: 3.959

4.  Liposomal amphotericin B in the treatment of fungal infections.

Authors:  G Lopez-Berestein
Journal:  Ann Intern Med       Date:  1986-07       Impact factor: 25.391

5.  Ultrafast computed tomography for infants and children.

Authors:  R C Brasch
Journal:  Radiol Clin North Am       Date:  1988-03       Impact factor: 2.303

6.  Favorable outcome of invasive aspergillosis in patients with acute leukemia.

Authors:  P A Burch; J E Karp; W G Merz; J E Kuhlman; E K Fishman
Journal:  J Clin Oncol       Date:  1987-12       Impact factor: 44.544

7.  Factors associated with fatal hemoptysis in cancer patients.

Authors:  R J Panos; L F Barr; T J Walsh; H J Silverman
Journal:  Chest       Date:  1988-11       Impact factor: 9.410

8.  Treatment of experimental murine candidiasis with liposome-associated amphotericin B.

Authors:  J Ahrens; J R Graybill; P C Craven; R L Taylor
Journal:  Sabouraudia       Date:  1984

9.  Selective toxicity and enhanced therapeutic index of liposomal polyene antibiotics in systemic fungal infections.

Authors:  R L Juliano; G Lopez-Berestein; R Hopfer; R Mehta; K Mehta; K Mills
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

10.  Treatment of experimental invasive aspergillosis with novel amphotericin B/cholesterol-sulfate complexes.

Authors:  T F Patterson; P Miniter; J Dijkstra; F C Szoka; J L Ryan; V T Andriole
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

View more
  25 in total

1.  Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia.

Authors:  Ruta Petraitiene; Vidmantas Petraitis; Andreas H Groll; Tin Sein; Robert L Schaufele; Andrea Francesconi; John Bacher; Nilo A Avila; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Toxicological profile and pharmacokinetics of a unilamellar liposomal vesicle formulation of amphotericin B in rats.

Authors:  G W Boswell; I Bekersky; D Buell; R Hiles; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

3.  Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models.

Authors:  F C Odds; F Van Gerven; A Espinel-Ingroff; M S Bartlett; M A Ghannoum; M V Lancaster; M A Pfaller; J H Rex; M G Rinaldi; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

4.  Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis.

Authors:  T J Walsh; P Whitcomb; S Piscitelli; W D Figg; S Hill; S J Chanock; P Jarosinski; R Gupta; P A Pizzo
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

5.  Efficacy of liposomal amphotericin B with prolonged circulation in blood in treatment of severe pulmonary aspergillosis in leukopenic rats.

Authors:  E W Van Etten; L E Stearne-Cullen; M ten Kate; I A Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

6.  Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis.

Authors:  Andrea Francesconi; Miki Kasai; Ruta Petraitiene; Vidmantas Petraitis; Amy M Kelaher; Robert Schaufele; William W Hope; Yvonne R Shea; John Bacher; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

7.  Environmental monitoring for Aspergillus fumigatus in association with an immunosuppressed rabbit model of pulmonary aspergillosis.

Authors:  Kimberly A Such; Vidmantas Petraitis; Ruta Petraitiene; Gittel E Strauss; Patriss-Wais Moradi; Thomas J Walsh
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-09       Impact factor: 1.232

8.  Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients.

Authors:  Birgit Spiess; Dieter Buchheidt; Corinna Baust; Heyko Skladny; Wolfgang Seifarth; Udo Zeilfelder; Christine Leib-Mösch; Handan Mörz; Rüdiger Hehlmann
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

9.  Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits.

Authors:  V Petraitis; R Petraitiene; A H Groll; A Bell; D P Callender; T Sein; R L Schaufele; C L McMillian; J Bacher; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

10.  Development and validation of a quantitative real-time PCR assay using fluorescence resonance energy transfer technology for detection of Aspergillus fumigatus in experimental invasive pulmonary aspergillosis.

Authors:  Cathal E O'Sullivan; Miki Kasai; Andrea Francesconi; Vidmantas Petraitis; Ruta Petraitiene; Amy M Kelaher; Alia A Sarafandi; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.